Altratech Team

We are a team of 17 scientists and engineers working together since 2016 (molecular biology, surface chemistry, microfluidics, and chip design) to bring together nano biotechnology, chemistry, and semiconductors to radically change the accessibility of high content genetic data.

Based on the novel Detection by Proxy concept, Altratech has developed the next generation of molecular detection. The technology enables any person, anywhere, to rapidly and accurately measure and quantify viral RNA, DNA, antigen, or antibody samples.


Dr. Tara Dalton

CEO


Dr. David McGuire

COO


Dr. Brian O’Farrell

CSO


Tim Cummins

CTO


Dr. Moira McCarthy

R&D Manager


Niall Olden

Chairman (Investor)
Kernel Capital


Cyril McGuire

(Investor)
Infinity Capital